293 related articles for article (PubMed ID: 31797441)
1. Overuse of venous thromboembolism prophylaxis among hospitalized patients with liver disease.
Davis JPE; O'Leary KE; Intagliata NM
Eur J Haematol; 2020 Mar; 104(3):223-229. PubMed ID: 31797441
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.
Shatzel J; Dulai PS; Harbin D; Cheung H; Reid TN; Kim J; James SL; Khine H; Batman S; Whyman J; Dickson RC; Ornstein DL
J Thromb Haemost; 2015 Jul; 13(7):1245-53. PubMed ID: 25955079
[TBL] [Abstract][Full Text] [Related]
3. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
Barclay SM; Jeffres MN; Nguyen K; Nguyen T
Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.
Moorehead KJ; Jeffres MN; Mueller SW
J Pharm Pract; 2017 Feb; 30(1):58-63. PubMed ID: 26475125
[TBL] [Abstract][Full Text] [Related]
7. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
9. Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis.
Amin A; Neuman WR; Lingohr-Smith M; Menges B; Lin J
Adv Ther; 2019 Jan; 36(1):59-71. PubMed ID: 30543037
[TBL] [Abstract][Full Text] [Related]
10. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
Henke PK; Kahn SR; Pannucci CJ; Secemksy EA; Evans NS; Khorana AA; Creager MA; Pradhan AD;
Circulation; 2020 Jun; 141(24):e914-e931. PubMed ID: 32375490
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience.
Abdel-Razeq HN; Hijjawi SB; Jallad SG; Ababneh BA
J Thromb Thrombolysis; 2010 Oct; 30(3):286-93. PubMed ID: 20127272
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa.
Rocher WD; Page T; Rocher M; Nel D
S Afr Med J; 2019 Feb; 109(3):178-181. PubMed ID: 30834875
[TBL] [Abstract][Full Text] [Related]
13. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
[TBL] [Abstract][Full Text] [Related]
14. VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study.
Zhai Z; Kan Q; Li W; Qin X; Qu J; Shi Y; Xu R; Xu Y; Zhang Z; Wang C;
Chest; 2019 Jan; 155(1):114-122. PubMed ID: 30300652
[TBL] [Abstract][Full Text] [Related]
15. [Venous thromboembolism risk and prophylaxis status of cancer inpatient].
Xu RH; Shi YK; Gao Y; Li WM; Qin XY; Qu JM; Zhai ZG; Wang C
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1100-1104. PubMed ID: 34695902
[No Abstract] [Full Text] [Related]
16. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.
Scoville EA; Konijeti GG; Nguyen DD; Sauk J; Yajnik V; Ananthakrishnan AN
Inflamm Bowel Dis; 2014 Apr; 20(4):631-6. PubMed ID: 24552828
[TBL] [Abstract][Full Text] [Related]
17. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Barkoudah E; Piazza G; Hecht TEH; Grant P; Deitelzweig S; Fang MC; Fanikos J; Kao CK; Barnes GD; Chen T; Ramishvili T; Schnipper JL; Goldstein JN; Ruff CT; Kaatz S; Schwartz A; Connors JM; Goldhaber SZ
Am J Med; 2020 May; 133 Suppl 1():1-27. PubMed ID: 32362349
[TBL] [Abstract][Full Text] [Related]
18. Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Dang JD; Davis LE
JAAPA; 2015 Jun; 28(6):27-8, 30. PubMed ID: 25989432
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
Yang LS; Alukaidey S; Croucher K; Dowling D
Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
[TBL] [Abstract][Full Text] [Related]
20. Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department.
Novo-Veleiro I; Alvela-Suárez L; Costa-Grille A; Suárez-Dono J; Ferrón-Vidan F; Pose-Reino A
BMJ Open; 2018 May; 8(5):e021288. PubMed ID: 29764885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
